Steven brings a blend of life sciences and commercial strategy to his role at biomodal, where he supports researchers across academia, biotech, and pharma in unlocking deeper biological insights through multiomic technologies.
With experience spanning proteomics, genomics, and now epigenetics, he specialises in translating complex innovations into actionable solutions that drive discovery and precision medicine.
Steven holds an MBA from Massachusetts College of Pharmacy and is passionate about people, working closely with customers to uncover opportunities, solve challenges, and maximise the impact of biomodal’s transformative platform in their research.